A phase I, open-label trial on the safety and immunogenicity of the adjuvanted tuberculosis subunit vaccine H1/IC31® in people living in a TB-endemic area
暂无分享,去创建一个
A. Aseffa | Martha Zewdie | J. Ahmed | Ingrid Kromann | S. Hoff | P. Bang | L. Yamuah | Alemnew F Dagnew | M. Abebe | H. Engers | Menberework Chanyalew | A. Bedru | T. Doherty | J. Hussein | Asfawesen G Yohannes